Regulation by post-translation modifications in response to stress

通过翻译后修饰来应对压力的调节

基本信息

项目摘要

Abstract Over a thousand human genes have dedicated roles in the ubiquitin pathway, making it one of the most complex signaling systems. About 650 of these genes encode ubiquitin ligases (E3s), which recognize substrates and target them for degradation. Our laboratory has developed several methods, based on both cell biological and affinity approaches, to identify substrates of ubiquitin ligases, and have used these to identify over two dozen substrates of five ligases. However, like phosphorylation, in many cases loss of ubiquitination has no obvious phenotype. We have used the R35 mechanism to completely re-configure ourselves into a mammalian cell laboratory and undertaken a large screen to identify phenotypes for poorly understood human E3s/DUBs. We created a CRISPR library against human E3s/DUBs and performed a pooled CRISPR-Cas9 screen combined with chemical inhibition of 41 compounds targeting genome integrity, cell cycle progression, transcription, RNA processing, translation, mitochondrial function, protein folding, metabolic pathways, transport, cytoskeleton, etc. By probing a diverse set of biological processes for E3/DUB involvement, we were able to assess the specificity of these interactions. Overall, we identified one or more specific interactions for 161 E3/DUBs (about 25% of those examined), many of which were previously unstudied. Some genes, such as FBXW7, showed interactions with more than one-third of the compounds. Others showed interactions only with a single compound or a set of related compounds. We are focusing our efforts on following up four sets of ligases: mutants in the poorly studied RING ligase RNF25 were extremely sensitive to alkylating agents, but not other forms of DNA damage; mutants in the unstudied CUL5 adaptor WSB2 were exquisitely sensitive to inhibitors of nuclear export; the CUL4 adaptor DCAF7 has a role in maintaining viability during a CDK4/6 arrest; and the poorly-characterized F-box protein FBXO42 has clear roles in mitosis. We will use both genetic screens and our established mass spec approaches to identify the relevant substrates of these ligases. In addition, we will continue with our analysis of ubiquitin linkages. We have carried out a large genetic interaction screen in yeast to identify roles of individual ubiquitin linkages. We will expand upon this screen and will carry out complementary mass spectrometry approaches to identify relevant substrates.
抽象的 超过一千个人类基因在泛素通路中发挥着专门的作用,使其成为最重要的通路之一。 复杂的信号系统。其中大约 650 个基因编码泛素连接酶 (E3),可识别 底物并以它们为目标进行降解。我们的实验室开发了几种基于细胞的方法 生物学和亲和方法,以鉴定泛素连接酶的底物,并使用这些方法来鉴定 五种连接酶的两打底物。然而,与磷酸化一样,在许多情况下泛素化会丢失 没有明显的表型。我们利用R35机制将自己彻底重新配置成一个 哺乳动物细胞实验室进行了大规模筛选,以确定对人类知之甚少的表型 E3/DUB。我们创建了针对人类 E3s/DUB 的 CRISPR 文库,并进行了混合 CRISPR-Cas9 结合针对基因组完整性、细胞周期进程的 41 种化合物的筛选和化学抑制, 转录、RNA 加工、翻译、线粒体功能、蛋白质折叠、代谢途径、 运输、细胞骨架等。通过探索 E3/DUB 参与的多种生物过程,我们 能够评估这些相互作用的特异性。总的来说,我们确定了一种或多种特定的相互作用 161 个 E3/DUB(约占所检查的 25%),其中许多以前未经研究。有些基因, 例如 FBXW7,显示出与超过三分之一的化合物存在相互作用。其他人则表现出互动 仅使用单一化合物或一组相关化合物。我们重点抓好四个方面的后续工作 连接酶组:研究不足的 RING 连接酶 RNF25 中的突变体对烷基化极其敏感 剂,但不是其他形式的 DNA 损伤;未研究的 CUL5 适配器 WSB2 中的突变体非常精致 对核输出抑制剂敏感; CUL4 适配器 DCAF7 在维持生存能力方面发挥着作用 CDK4/6 逮捕;特征不明的 F-box 蛋白 FBXO42 在有丝分裂中具有明确的作用。我们将同时使用 遗传筛选和我们建立的质谱方法来识别这些连接酶的相关底物。 此外,我们将继续对泛素连接进行分析。我们进行了一次大型遗传 在酵母中进行相互作用筛选,以确定单个泛素连接的作用。我们将在此屏幕上展开并 将采用补充质谱方法来识别相关底物。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Paul Toczyski其他文献

David Paul Toczyski的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Paul Toczyski', 18)}}的其他基金

Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
  • 批准号:
    10438061
  • 财政年份:
    2022
  • 资助金额:
    $ 73.67万
  • 项目类别:
Characterizing the role of RNF25 in repair of DNA alkylation in blood cancers
表征 RNF25 在血癌 DNA 烷基化修复中的作用
  • 批准号:
    10580070
  • 财政年份:
    2022
  • 资助金额:
    $ 73.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    10098111
  • 财政年份:
    2016
  • 资助金额:
    $ 73.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    10801759
  • 财政年份:
    2016
  • 资助金额:
    $ 73.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    10609884
  • 财政年份:
    2016
  • 资助金额:
    $ 73.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    10198226
  • 财政年份:
    2016
  • 资助金额:
    $ 73.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    9071173
  • 财政年份:
    2016
  • 资助金额:
    $ 73.67万
  • 项目类别:
Regulation by post-translation modifications in response to stress
通过翻译后修饰来应对压力的调节
  • 批准号:
    9982380
  • 财政年份:
    2016
  • 资助金额:
    $ 73.67万
  • 项目类别:
Identifying the targets of oncogenic/tumor-suppressive F box proteins
鉴定致癌/肿瘤抑制 F 盒蛋白的靶标
  • 批准号:
    9016501
  • 财政年份:
    2015
  • 资助金额:
    $ 73.67万
  • 项目类别:
Cell cycle regulation by ubiquitin ligases
泛素连接酶的细胞周期调节
  • 批准号:
    7995625
  • 财政年份:
    2010
  • 资助金额:
    $ 73.67万
  • 项目类别:

相似海外基金

Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
  • 批准号:
    10374792
  • 财政年份:
    2021
  • 资助金额:
    $ 73.67万
  • 项目类别:
Elucidation and prevention of the mechanism of hepatic sinusoidal obstruction syndrome (SOS) induced by DNA alkylating agents
DNA烷化剂诱发肝窦阻塞综合征(SOS)机制的阐明和预防
  • 批准号:
    21K15255
  • 财政年份:
    2021
  • 资助金额:
    $ 73.67万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Differential resistance mechanisms to monofunctional vs bifunctional alkylating agents in glioma
神经胶质瘤对单功能烷化剂与双功能烷化剂的不同耐药机制
  • 批准号:
    10570900
  • 财政年份:
    2021
  • 资助金额:
    $ 73.67万
  • 项目类别:
Development of individualized therapy by elucidation of molecular mechanisms for hypermutation phenotype induced by treatment with alkylating agents in glioma
通过阐明神经胶质瘤中烷化剂治疗诱导的超突变表型的分子机制来开发个体化治疗
  • 批准号:
    18K09004
  • 财政年份:
    2018
  • 资助金额:
    $ 73.67万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Reversing intrinsic cancer cell resistance to alkylating agents by histone deacetylase inhibition
通过组蛋白脱乙酰酶抑制逆转癌细胞对烷化剂的内在耐药性
  • 批准号:
    214657440
  • 财政年份:
    2012
  • 资助金额:
    $ 73.67万
  • 项目类别:
    Research Grants
Rerouting alkylating agents to the mitochondria for cancer therapy
将烷化剂重新路由至线粒体用于癌症治疗
  • 批准号:
    247842
  • 财政年份:
    2011
  • 资助金额:
    $ 73.67万
  • 项目类别:
    Studentship Programs
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8105413
  • 财政年份:
    2010
  • 资助金额:
    $ 73.67万
  • 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8271313
  • 财政年份:
    2010
  • 资助金额:
    $ 73.67万
  • 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8730259
  • 财政年份:
    2010
  • 资助金额:
    $ 73.67万
  • 项目类别:
Novel approaches to enhance tumor cell cytotoxicity of alkylating agents
增强烷化剂肿瘤细胞细胞毒性的新方法
  • 批准号:
    8676463
  • 财政年份:
    2010
  • 资助金额:
    $ 73.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了